Autoimmune Diseases  >>  RNS60  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RNS60 / Revalesio
NCT01714089: Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis

Withdrawn
2
0
US
RNS60 125 ml, RNS60 250 ml, Interferon beta 1a
Revalesio Corporation
Relapsing Remitting Multiple Sclerosis
 
 

Download Options